ACT-335827
ACT-335827 is an orally available, selective orexin 1 receptor antagonist with anxiolytic effects in animals.
≈ 1 min read
Names in other languages
No names in other languages are held for this entry yet.
Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.
ACT-335827 is an orally available, selective orexin 1 receptor antagonist with anxiolytic effects in animals. Unlike other orexin receptor antagonists, ACT-335827 lacks sedative effects and was found to have no impact on sleep architecture in mice.
Text derived from https://en.wikipedia.org/w/index.php?oldid=1370556631 under CC BY-SA 4.0; modifications have been made.